Rebif Sales Data

Rank 50 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Rebif U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 50 (9) -6.27% -12.61%
Q3 2013 41 (3) -8.17% -14.07%
Q2 2013 38 (3) -1.96% -6.41%
Q1 2013 41 (3) 6.61% -8.17%
Q4 2012 38 (4) 1.13% -3.92%
Q3 2012 42 (7) 8.88% 11.36%
Q2 2012 49 (13) 9.73% 5.93%
Q1 2012 62 (1) -0.21% -9.09%
Q4 2011 61 (7) 0.43% -0.34%
Q3 2011 54 (5) 1.48% -1.49%
Q2 2011 59 (2) 0.25% -0.66%
Q1 2011 61

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
April 2, 2014Rare, But Serious, Side Effect Reported With One MS Drug
Hide
(web5)